The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
October 25th 2024
New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
To Answer Patient Questions, Physicians Turn to New Information Sources
July 14th 2014In a recent survey, physicians identified peer-reviewed journal articles, continuing medical education, evidence-based guidelines, and national experts as the most useful sources of information to stay current on therapeutic advances.
Fatality Risk Falling in Total Hip Replacement
July 9th 2014Thanks to better anesthetics, new surgical techniques, and more consistent anticoagulant use to prevent venous thromboembolism, mortality after total hip replacement surgery is rare. Nevertheless, a patient's risk of death briefly increases following the procedure.
Insertable External Cardiac Monitors Better than ECG for Post-Stroke Atrial Fibrillation Detection
A pair of randomized controlled studies have both found that continuous monitoring of patients after cryptogenic strokes can detect several times as many cases of atrial fibrillation as conventional monitoring.
Combining Cessation Therapies Helps Highly Nicotine-dependent Males Quit Smoking
July 2nd 2014Among highly nicotine-dependent male smokers, therapies that combine smoking cessation agents significantly increase the likelihood of quitting, according to a study published in The American Journal of Psychiatry.
Weight Loss Improves Disease Management in Patients with Psoriatic Arthritis
July 1st 2014Study results show that obese patients with psoriatic arthritis who were treated with tumor necrosis factor-alpha blockers who also lost at least 5 percent of their bodyweight from baseline were much more likely to achieve minimal disease activity.
Benefits of Azithromycin Outweigh Risks in Elderly Hospitalized with Pneumonia
Among patients aged 65 years or older who are hospitalized with community-acquired pneumonia, azithromycin lowers the risk of 90-day mortality in exchange for slightly increased odds of myocardial infarction compared to other antibiotic regimens.
Left Untreated, Moderate Aortic Valve Stenosis Has High Mortality Risk
June 30th 2014Although valve replacement is indicated when aortic valve stenosis (AS) is severe, experts have struggled with crafting evidence-based recommendations in the presence of mild or moderate AS, which has led to inconsistent practices and surgical guidelines.
Implantable Device Reduces Hospitalizations and Other Risks Associated with Atrial Fibrillation
New research financed by Medtronic Inc. suggests that implantable cardiac resynchronization therapy devices governed by its new algorithms may reduce atrial fibrillation-related complications in patients who have experienced heart failure.
Prophylaxis Protocols Improve Post-op Venous Thromboembolism Outcomes
June 25th 2014By emphasizing early postoperative mobilization alongside mandatory venous thromboembolism (VTE) risk stratification and concurrent electronic prophylaxis recommendations, hospitals can significantly reduce the likelihood of VTE complications among surgical patients.
Does Exercise Actually Increase Your Risk of Atrial Fibrillation?
Data from a large cohort of Swedish men suggest that regular vigorous exercise starting around age 30 may increase the risk of atrial fibrillation, particularly among those who stop exercising later in life.
Preventive Implantable Cardioverter-defibrillators Improve Survival in Heart Failure Patients
A retrospective cohort study of Medicare beneficiaries hospitalized for heart failure with a left ventricular ejection fraction between 30-35% found improved 3-year survival rates among those who received a prophylactic implantable cardioverter-defibrillators compared to those with no ICD.